KRISTEN BELL: Open Payments
NPI 1013104652 · POOLER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,752 in 99 payments from 15 companies in 2025. Trend: 2023 $1,635 · 2024 $1,941 · 2025 $1,752
Food & beverage: $1,752
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $373 |
| QOL Medical, LLC | 8 | $352 |
| Janssen Biotech, Inc. | 25 | $341 |
| Ardelyx, Inc. | 12 | $178 |
| Phathom Pharmaceuticals, Inc. | 13 | $172 |
| GENZYME CORPORATION | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
| Ipsen Biopharmaceuticals, Inc | 2 | $35 |
Products named: Sucraid, TREMFYA, IBSRELA, VOQUEZNA, RINVOQ, CREON, LINZESS, DUPIXENT.
Industry payments across GA — which companies pay providers there.
